Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers

This study has been completed.
Sponsor:
Collaborators:
Cato Research
Information provided by (Responsible Party):
VistaGen Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01483846
First received: November 16, 2011
Last updated: December 18, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)